galectin-9 therapy (Blood Systems Research Institute)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namegalectin-9 therapy (Blood Systems Research Institute)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGalactoside-binding lectin Galectin 9 modulators
TargetsGalactoside-binding lectin Galectin 9
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVitalant Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVitalant Research Institute
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A